A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

被引：0
|
作者：
Taisuke Mori
Kenichi Hosokawa
Yoshiyuki Kinoshita
Ai Watanabe
Takeshi Yamaguchi
Haruo Kuroboshi
Yoshiko Kato
Jinsuke Yasuda
Hiroyuki Fujita
Yoshinori Nakata
Hideo Honjo
机构：
[1] Kyoto Prefectural University of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2007年 / 12卷
关键词：
Ovarian cancer; Docetaxel; Paclitaxel; Toxicity; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：205 / 211
页数：6
相关论文
共 50 条
  • [31] Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: A prospective EEG mapping study in 28 patients
    Mayerhofer, K
    Bodner, K
    Saletu, B
    Bodner-Adler, B
    Anderer, P
    Hefler, L
    Schindl, M
    Kaider, A
    Leodolter, S
    Kainz, C
    ANTICANCER RESEARCH, 2001, 21 (1B) : 803 - 808
  • [32] Five cases of skin desquamation due to bevacizumab combined with docetaxel-carboplatin in ovarian cancer
    Tokunaga, Megumi
    Nawata, Shuichi
    Komoto, Takayuki
    Mathuura, Rei
    Ichikura, Daisuke
    Watanabe, Toru
    Sasaki, Tadanori
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2023, 12 (01) : 49 - 52
  • [33] Usefulness of desensitization protocol for a carboplatin hypersensitivity reaction during docetaxel-carboplatin therapy for recurrent ovarian cancer: Case report
    Shoji, Tadahiro
    Takatori, Eriko
    Kaido, Yoshitaka
    Kumagai, Seisuke
    Takeuchi, Satoshi
    Yoshizaki, Akira
    Sugiyama, Toru
    ONCOLOGY LETTERS, 2010, 1 (06) : 1021 - 1023
  • [34] A Comparative Clinical Study of the Docetaxel-Carboplatin combination and the Gemcitabine-Carboplatin combination in Patients with Non Small Cell Lung Cancer
    Sumanth, M.
    Philipj
    Radheshyam
    Ulla
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2008, 2 (04) : 946 - 951
  • [35] Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy
    Takemoto, Shuji
    Ushijima, Kimio
    Honda, Kazumi
    Wada, Hiroko
    Terada, Atsumu
    Imaishi, Hiroto
    Kamura, Toshiharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (04) : 367 - 372
  • [36] Docetaxel in combination with carboplatin for chemo-naive patients with epithelial ovarian cancer
    Aoki, Y
    Sato, T
    Tsuneki, I
    Watanabe, M
    Kase, H
    Fujita, K
    Kurata, H
    Tanaka, K
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) : 704 - 709
  • [37] Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer:: A phase II study
    Mäenpää, JU
    Grénman, SE
    Jalkanen, JT
    Kuoppala, TA
    Leminen, AO
    Puistola, US
    Vuolo-Merilä, PM
    Yliskoski, MH
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 114 - 119
  • [38] A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
    Secord, A. Alvarez
    Havrilesky, L. J.
    Higgins, R. V.
    Nycum, L. R.
    Kohler, M. F.
    Puls, L. E.
    Holloway, R.
    Soper, J. T.
    Valea, F. A.
    Berchuck, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 278S - 278S
  • [39] Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
    Tan, Xiangbin
    Zou, Shuangyou
    Chen, Hui
    Chen, Dachao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [40] Paclitaxel/Carboplatin and Lonafanib versus Paclitaxel/Carboplatin in patients with ovarian epithelial cancer FOGO IIB-IV Conclusion on toxicity of prospective randomize multicentr phase 2 study
    Gropp, M.
    Sehouli, J.
    du Bois, A.
    Burchardi, N.
    Baumann, K.
    Meier, W.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S13 - S13
12345